Search Results - "Maestro, M.L"

Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer by Sotelo, M.J., Sastre, J., Maestro, M.L., Veganzones, S., Viéitez, J.M., Alonso, V., Grávalos, C., Escudero, P., Vera, R., Aranda, E., García-Alfonso, P., Gallego-Plazas, J., Lopez, C., Pericay, C., Arrivi, A., Vicente, P., Ballesteros, P., Elez, E., López-Ladrón, A., Díaz-Rubio, E.

“…This is the first study that seeks to establish the prognostic value of circulating tumor cell (CTC) (determined by CellSearch system) in patients with stage…”
Get full text

Role of Fibroblast Growth Factor 23 (FGF23) in the Metabolism of Phosphorus and Calcium Immediately After Kidney Transplantation by Sánchez Fructuoso, A.I, Maestro, M.L, Calvo, N, De La Orden, V, Pérez Flores, I, Vidaurreta, M, Valero, R, Fernández-Pérez, C, Barrientos, A

“…Abstract Introduction Persistence of inappropriately high serum levels of fibroblast growth factor-23 (FGF23), a recently discovered phosphaturic hormone, has…”
Get full text

The Prevalence of Uridine Diphosphate-Glucuronosyltransferase 1A9 (UGT1A9) Gene Promoter Region Single-Nucleotide Polymorphisms T-275A and C-2152T and Its Influence on Mycophenolic Acid Pharmacokinetics in Stable Renal Transplant Patients by Sánchez-Fructuoso, A.I, Maestro, M.L, Calvo, N, Viudarreta, M, Pérez-Flores, I, Veganzone, S, De la Orden, V, Ortega, D, Arroyo, M, Barrientos, A

“…Abstract The aim of this study was to evaluate the distribution of UGT1A9 promoter region T-275A and C-2152T single nucleotide polymorphisms (SNPs) in stable…”
Get full text

Diagnostic and predictive value of urine PCA3 gene expression for the clinical management of patients with altered prostate-specific antigen by Rodón, N, Trías, I, Verdú, M, Román, R, Domínguez, A, Calvo, M, Banus, J.M, Ballesta, A.M, Maestro, M.L, Puig, X

“…Abstract Objective Analyze the impact of the introduction of the study of PCA3 gene in post-prostatic massage urine in the clinical management of patients with…”
Get full text

Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables by Sastre, J., Maestro, M. L., Puente, J., Veganzones, S., Alfonso, R., Rafael, S., García-Saenz, J. A., Vidaurreta, M., Martín, M., Arroyo, M., Sanz-Casla, M. T., Díaz-Rubio, E.

“…Background: The CellSearch System is a technique to detect circulating tumor cells (CTCs) in patients with cancer. Few data have been published concerning the…”
Get full text

Tissue quantification of CA 125 in epithelial ovarian cancer by de la Cuesta, R, Maestro, M L, Solana, J, Vidart, J A, Escudero, M, Iglesias, E, Valor, R

“…The objectives of this study were the determination of CA 125 in the cytosol of healthy and carcinomatous ovarian tissue by immunoanalysis, analysis of its…”
Get more information

347 POSTER Molecular detection of micrometastasis of sentinel nodes enhances prognostic information for the patient by Moreno, A., Roman, J.M., Campo, I., Merchan, M.J., Beganzones, S., Vidaurreta, M., Maestro, M.L., Martin, M., Rodriguez, B., Vidart, J.A.

Get full text

p16 Gene methylation in colorectal tumors: correlation with clinicopathological features and prognostic value by Sanz-Casla, M T, Maestro, M L, Vidaurreta, M, Maestro, C, Arroyo, M, Cerdán, J

“…Methylation of the CpG islands in the p16 gene promoter region is an important transcription repression mechanism that has been identified as an alternative…”
Get more information

Prognostic value of cathepsin D in breast cancer (BC) patients by Adrover, E., Maestro, M.L., Sanz-Casla, T., Del Barco, V., Valor, R.

Get full text

Prognostic value of the quantified expression of p185c-erbb2 in non–small cell lung cancer by Cantero, R., Torres, A.J., Maestro, M.L., Hernando, F., Sanz, M.T., del Barco, V., Gómez, A., Fernández, C., Balibrea, J.L.

“…Background: We sought to assess the relationship between tissue concentration of erb -b-2 or neu oncogene-encoded protein (p185 neu) with overall survival in…”
Get full text

Loss of heterozygosity on the short arm of chromosome 3 in renal cancer by Maestro, M L, del Barco, V, Sanz-Casla, M T, Moreno, J, Adrover, E, Izquierdo, L, Zanna, I, Fernández, C, Redondo, E, Blanco, J, Resel, L

“…3% of human cancers are renal cell carcinomas (RCC). The most common chromosome abnormality found in this tumor is loss of heterozygosity (LOH) on the short…”
Get more information

Estudio de la inestabilidad microsatélite en tumores borderline y carcinoma de ovario by Vidaurreta, M., Almansa, I., Sanz, M.T., Tresserra, F., López, L., Maestro, M.L., Dexeus, S.

“…El objetivo de nuestro estudio es determinar la inestabilidad de tres microsatélites (BAT25, BAT26 y NME1) y observar si está implicada en el desarrollo de los…”
Get full text

Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer by Diez, M, Gomez, A, Hernando, F, Ortega, M D, Maestro, M L, Torres, A, Mugüerza, J M, Gutierrez, A, Granell, J, Balibrea, J L

“…Carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCC), and CA125 were determined pre- and postoperatively in non-small cell lung cancer…”
Get more information

Analytical and clinical evaluation of a procedure for measuring CA 15-3 in the IMx analyser by Ortega, M D, Maestro, M L, Encabo, G, Varón, C, Allende, M T, Martinez, I, Palacios, G

“…CA 15-3 is the most widely used tumour marker in the follow-up of patients with breast cancer. Its postoperative blood level is closely related to the response…”
Get more information

Tumor markers in pancreatic cancer: a comparative clinical study between CEA, CA 19-9 and CA 50 by Molina, L M, Díez, M, Cava, M T, Maestro, M L, Ortega, M D, Mendíz, J G, Prego, A, De Diego, J A, Balibrea, J L

“…Seventy-eight patients were evaluated to ascertain the usefulness of markers CA 19-9 and CA 50 in diagnosing pancreatic cancer, using a less specific marker…”
Get more information